CHAPEL HILL, N.C., Oct. 14 /PRNewswire/ -- Most bio-pharmaceutical organizations eventually have to face the challenge of managing multiple brands for the same indication. While a new product opens the door to more patients, it also can erode the market share of an organization's legacy product. The